MatriSys Bioscience, founded in the United States, is a biopharmaceutical company dedicated to developing rational microbiome therapies. Their core mission is to transform the treatment of chronic skin diseases through innovative biopharmaceuticals derived from beneficial bacteria found on healthy human skin. The company's groundbreaking technology platform aims to address the needs of millions of children and adults suffering from difficult-to-treat skin conditions.

Notable figures affiliated with MatriSys Bioscience include leading scientists and experts in microbiome research. The company has attracted significant investment from key players in the biotech industry, underscoring its potential impact. MatriSys Bioscience has achieved critical milestones in the discovery and clinical development phases, positioning itself as a pioneer in microbiome-based therapies. Their work promises to revolutionize dermatological treatments, offering new hope for patients with chronic skin diseases.